首页> 外文期刊>Medical Devices: Evidence and Research >The Impact of Age on the Outcomes of Minimally Invasive Lumbar Decompression for Lumbar Spinal Stenosis
【24h】

The Impact of Age on the Outcomes of Minimally Invasive Lumbar Decompression for Lumbar Spinal Stenosis

机译:年龄对腰椎狭窄的微创腰椎减压的影响

获取原文
           

摘要

Background and Purpose: Minimally invasive lumbar decompression ( mild sup?/sup) is an effective long-term therapy for patients with symptomatic lumbar spinal stenosis (LSS) resulting primarily from hypertrophic ligamentum flavum (HLF). Most subjects in clinical studies of the mild procedure have been older adults (age≥ 65). While the incidence of LSS increases with age, a substantial number of adults (age 65) also suffer from neurogenic claudication secondary to HLF. In this report, outcomes of mild were compared between adults and older adults. Patients and Methods: All prospective studies of the mild procedure with a 1-year follow-up completed since the beginning of 2012 that allowed the inclusion of adult patients of all ages were reviewed. Outcomes of visual analog scale (VAS), Oswestry Disability Index (ODI), Pain Disability Index (PDI), Roland Morris Low Back Pain and Disability Questionnaire (RMQ), standing time and walking distance were compared for adults and older adults. Results: Four studies met the inclusion criteria, resulting in an analysis of 49 adults and 160 older adults. Patients in both age groups experienced significant mean improvements in all but one outcome measure at 6- and 12-month follow-up. Differences between the two age groups in all scores at 6 and 12 months were not statistically significant. Conclusion: Analysis of the four studies indicated that symptom improvements for adults and older adults were significant from baseline, and no statistically significant difference was observed between the two age groups. These results illustrate that mild can be an effective treatment for LSS due primarily to HLF, regardless of the adult patient age.
机译:背景和目的:微创腰椎减压(Mild )是患有症状腰椎狭窄(LSS)患者的有效的长期治疗,主要来自肥厚韧带韧带(HLF)。 MILD程序的临床研究中的大多数受试者已经成年人(年龄≥65)。虽然LSS的发生率随着年龄的增长而增加,但大量的成年人(年龄<65)也患有次到HLF的神经源性跛行。在本报告中,在成人和老年人之间比较了轻度的结果。患者和方法:自2012年初完成的均为1年后的温和手术的所有前瞻性研究允许纳入所有年龄段的成年患者。对成年人和老年人进行了比较了视觉模拟规模(VAS),OSWestry残疾指数(ODI),止痛性指数(PDI),罗兰莫里斯低腰疼痛和残疾问卷调查问卷(ROLAND),延迟时间和步行距离。结果:四项研究达到了纳入标准,导致49名成人和160名老年人的分析。两岁患者的患者在6-10个随访时间内的所有结果均可均有显着的改善。在6和12个月的所有分数中,两个年龄组之间的差异在统计学上没有统计学意义。结论:对四项研究的分析表明,成人和老年人的症状改善是从基线中显着的,并且在两龄龄群之间没有观察到统计学意义的差异。这些结果表明,无论成年患者年龄如何,Mild都可以是主要对LSS的有效治疗LSS。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号